Eli Lilly and Company Total Current Liabilities 2011-2026 | LLY

Annual Total Current Liabilities Eli Lilly and Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
35.2 B	28.4 B	27.3 B	17.1 B	15.1 B	12.5 B	11.8 B	11.9 B	14.5 B	11 B	8.23 B	11.2 B	8.92 B	8.39 B	8.93 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
35.2 B	8.23 B	15.4 B

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	1.47 B	$ 333.39	-1.77 %	$ 43.7 B	USA
Can-Fite BioPharma Ltd. CANF	2.73 M	$ 3.17	3.93 %	$ 5.22 M	Israel
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
AlloVir ALVR	9.71 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Aligos Therapeutics ALGS	21.2 M	$ 7.42	-15.1 %	$ 73.3 M	USA
Allakos ALLK	36.6 M	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Applied Therapeutics APLT	71.2 M	-	-	$ 8.42 M	USA
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	22.1 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	158 M	$ 21.68	1.4 %	$ 1.01 B	USA
Cabaletta Bio CABA	50.2 M	$ 3.4	4.29 %	$ 342 M	USA
CymaBay Therapeutics CBAY	36.8 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	20.8 M	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	163 M	-	-	$ 399 M	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	47.6 M	$ 4.24	2.17 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	130 M	$ 24.58	-2.03 %	$ 3.13 B	USA
AIkido Pharma AIKI	1.61 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	73.4 M	$ 1.49	0.68 %	$ 397 M	Britain
Aptose Biosciences APTO	9.31 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	5.61 M	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	51 M	$ 33.87	1.62 %	$ 2.25 B	USA
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	6.81 M	-	-	$ 25.3 M	USA
bluebird bio BLUE	200 M	-	-	$ 546 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA